Skip to main content
. 2022 Jun 18;11(1):33. doi: 10.1038/s41389-022-00410-w

Fig. 6. Genome-wide CRISPR knockout screens identify a differential set of genetic determinants of cellular sensitivity to the ATM inhibitor KU55933 in wildtype compared to BRCA2-knockout HeLa cells.

Fig. 6

A Overview of the CRISPR knockout screens to identify genes that differentially regulate the sensitivity of wiltdype and BRCA2-knockout HeLa cells to KU55933. B Scatterplot showing the results of genome-wide CRISPR knockout screens for cellular sensitivity to the ATM inhibitor KU55933 in wildtype and BRCA2-knockout HeLa cells. Each gene targeted by the library was ranked according to the MAGeCK score indicating genes which, when inactivated, cause specific sensitivity to HeLa-BRCA2KO cells compared to wild-type HeLa cells. Top hits chosen for validation are indicated. C Gene Ontology analysis of the top hits with a score <0.005 which cause specific KU55933 sensitivity to BRCA2-knockout compared to wild-type HeLa cells. GO_BP terms with a negative logP of 1.85 or lower are shown. D Gene Ontology analysis of the top hits with a score < 0.005 which cause specific KU55933 sensitivity to wildtype compared to BRCA2-knockout HeLa cells. GO_BP terms with a negative logP of 1.6 or lower are shown E. Table showing the ranks, and the biological functions of the hits chosen for subsequent validation. F, G Cellular survival assays showing that knockdown of RAD17, MDC1, or USP28 results in KU55933 sensitivity in HeLa-BRCA2KO cells (F), but not in wild-type HeLa cells (G). The average of three experiments is shown. Error bars represent standard deviations, and asterisks indicate statistical significance (t-test, two-tailed, unpaired). Western blots confirming the knockdown are shown in Supplementary Fig. S4C–E.